SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
惠向雁
Lv2
1
150 积分
2022-01-07 加入
最近求助
最近应助
互助留言
B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled tria
27天前
已完结
TGFB1 Induces Fetal Reprogramming and Enhances Intestinal Regeneration
1个月前
已完结
The Influence of Different Disease States on Rituximab Pharmacokinetics
2个月前
已完结
Rituximab Exhibits a Long Half-Life Based on a Population Pharmacokinetic Analysis in Non-Hodgkin’s Lymphoma (NHL) Patients
2个月前
已完结
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial
2个月前
已完结
Single-cell meta-analysis of inflammatory bowel disease with scIBD
2个月前
已完结
Rituximab Exhibits a Long Half-Life Based on a Population Pharmacokinetic Analysis in Non-Hodgkin’s Lymphoma (NHL) Patients
4个月前
已完结
Association Between Plasma Rituximab Concentration and the Risk of Major Relapse in Antineutrophil Cytoplasmic Antibody–Associated Vasculitides During Rituximab Maintenance Therapy
4个月前
已完结
Rituximab Exhibits a Long Half-Life Based on a Population Pharmacokinetic Analysis in Non-Hodgkin’s Lymphoma (NHL) Patients
4个月前
已关闭
Risk Factors Associated with the Occurrence of Anti-rituximab Antibodies in Membranous Nephropathy
4个月前
已完结
没有进行任何应助
非常感谢
3年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论